Collectively, these results demonstrated that PKNOX2 plays an essential inhibitory role in pathological myocardial fibrosis and might be a potential therapeutic target in myocardial remodelling during heart failure. The gene discussed is PKNOX2; the disease is Myocardial fibrosis.